Value of Point of Care Testing in Covid-19

Webinar • Abbott Rapid Diagnostics International

About the CPD course

This video seminar features two expert speakers discussing:1.Diabetes management in the time of COVID-19 and the value of HbA1c point-of-care testing (POCT) 2.C-reactive protein (CRP) in the context of COVID-19 and CRP as an aid to reduce antibiotic prescribing in respiratory infections.Diabetes patients are more likely to experience severe complications and higher mortality if they contract COVID-19; especially those with poorly managed diabetes. POCT for HbA1c aids in achieving improved glycaemic control. CRP can reflect disease severity and may be an independent predictor of adverse outcome in COVID-19 patients.

CPD Provider

Abbott Rapid Diagnostics International

View Profile

Send an enquiry

Full Name*

Email Address*

Contact Number*

Industry*

Your Enquiry*

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Abbott Rapid Diagnostics International

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.